Open platform Chai markets an open, connected PCR platform with a mobile field-oriented capability through a touch-screen and hotspot. Sales opportunities exist in labs seeking rapid design, run, and analysis as well as field deployments in remote locations—appealing to academic cores, contract labs, and field testing teams.

Reagent leadership The company highlights cutting-edge, thermally stable reagents, carry-over contamination prevention, high multiplexing, and streamlined extraction solutions. This positions Chai to upsell integrated kits and enhanced workflow solutions to labs needing faster, more reliable PCR workflows and scalable pathogen panels.

Beyond the lab Chai emphasizes application-specific test kits for breweries, food safety, COVID testing, and agricultural safety. There are clear cross-sell opportunities to industries that require portable, accurate testing solutions, including beverage, dairy, produce, and pest management sectors.

Ambitious accessibility With a mission to make research-grade biotechnology accessible and a mobile lab capability, there is potential to target small-to-medium enterprises, startups, and field services that need compact, easy-to-use PCR tools for on-site diagnostics, quality control, and environmental testing.

Tech-enabled ecosystem A tech stack leveraging AWS, analytics, and an open hardware platform suggests opportunities for service contracts, training, and workflow automation partnerships. Focus on expanding integration with customer IT and LIMS, as well as support for developers building on the platform.